JP2001212236A - Syringe/container - Google Patents
Syringe/containerInfo
- Publication number
- JP2001212236A JP2001212236A JP2000400690A JP2000400690A JP2001212236A JP 2001212236 A JP2001212236 A JP 2001212236A JP 2000400690 A JP2000400690 A JP 2000400690A JP 2000400690 A JP2000400690 A JP 2000400690A JP 2001212236 A JP2001212236 A JP 2001212236A
- Authority
- JP
- Japan
- Prior art keywords
- cylinder
- syringe
- sealing plug
- container
- barrel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は薬液、栄養剤などを
人体に投与する注射器兼容器に関し、詳しくは注射器内
を二室に分離して各々に薬成分を保存しておき、投与の
際に二室の薬を速やかに混合し、極めて衛生的に投与で
きる注射器兼容器の改良に関するBACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a syringe / container for administering a medicinal solution, a nutrient or the like to a human body. More specifically, the syringe is divided into two chambers, each of which stores a drug component and which is used for administration. Improving a syringe / container that can mix two chambers quickly and administer it extremely hygienically
【0002】[0002]
【従来の技術】薬液、栄養剤などを予め注射器に充填
し、保管し、簡単な操作でその容器そのものが注射器と
なり得る、注射器兼容器としては、すでに実開昭57−
79539号、実開昭59−2343号、特開昭48−
76390号、特開昭48−16489号、特開昭52
−149894号、特開昭59−120166号、特開
昭60−501193号、特開昭61−502099
号、特開平1−502086号、特公昭62−2538
9号公報等が知られている。2. Description of the Related Art A syringe is filled with a drug solution, a nutrient and the like in advance, stored, and the container itself can be used as a syringe by a simple operation.
No. 79439, Japanese Utility Model Application Laid-Open No. 59-2343, Japanese Unexamined Patent Application Publication No.
No. 76390, JP-A-48-16489, JP-A-52
JP-A-149894, JP-A-59-120166, JP-A-60-501193, JP-A-61-502099
No., JP-A-1-502086, JP-B-62-2538
No. 9 is known.
【0003】さらに、一つの注射器兼容器内に二種類の
薬品、例えば薬品と溶剤又は薬液と薬液等を保存し、投
与の際に両者を混合又は溶解して投与できるようにした
注射器の従来例としては、特開昭51−11691号、
同52−22391号、同58−61755号、同58
−212453号、同59−155264号、同59−
155264号、同60−72561号、同61−48
377号、同62−5357号、特開平2−5973
号、同3−82476号、同4−96762号、実公昭
49−14465号、同54−22315号、実開平2
−58446号、同3−29145号の等の各公報に記
載の技術が知られている。Further, a conventional example of a syringe in which two kinds of medicines, for example, a medicine and a solvent or a medicine and a medicine, are stored in one syringe and container, and both can be mixed or dissolved for administration. As described in JP-A-51-11691,
Nos. 52-22391, 58-61755, and 58
-212453, 59-155264, 59-
No. 155264, No. 60-72561, No. 61-48
377, 62-5357, JP-A-2-5973
No. 3-82476, No. 4-96762, No. 49-14465, No. 54-22315, No. 2
The technology described in each gazette such as -58446 and 3-29145 is known.
【0004】図15及び図16に公知の二室式注射器兼
容器の一例を示す。該注射器は、第1密封栓33を境と
して二室に分かれ、二室に保持する薬を用時に混合する
ことができる。即ち、筒29の一端は開口部31とな
り、その末端に指かけ用フランジ32を設けてある。他
の先端部30は細長くなっていて、先端はゴム栓で密封
されている。筒29内には第1密封栓33と第2密封栓
34が嵌着されていて、筒内を第1室35と第2室36
に分割して、図示の例では第1室35に粉末薬30を、
第2室36に蒸留水を保持している。また、筒29のほ
ぼ中央先端よりに1個のバイパス部37を設けてあり、
薬の溶解・混合の際には押し棒(図示せず)によって第
2密封栓34を先端側に移動し、蒸留水を介して第1密
封栓33を図中鎖線で示す先端側のバイパス部37の位
置に移動させることにより第2室36の蒸留水は第1室
35に流れ込んで第1室内の粉末薬30と混合され薬を
溶解して投与できる薬液となる。バイパス部のE−E′
断面は図16に示すように、筒外周と筒内壁は同じ厚さ
でバイパス部37において外側に突き出した形状に設計
されている。FIGS. 15 and 16 show an example of a known two-chamber syringe / container. The syringe is divided into two chambers with the first sealing stopper 33 as a boundary, and the medicine held in the two chambers can be mixed at the time of use. That is, one end of the cylinder 29 becomes an opening 31 and a finger hanging flange 32 is provided at the end. The other tip 30 is elongated and the tip is sealed with a rubber stopper. A first sealing plug 33 and a second sealing plug 34 are fitted in the cylinder 29, and a first chamber 35 and a second chamber 36
In the example shown, the powder medicine 30 is placed in the first chamber 35,
The second chamber 36 holds distilled water. Also, one bypass portion 37 is provided substantially at the center end of the cylinder 29,
At the time of dissolving and mixing the medicine, the second sealing stopper 34 is moved to the distal end side by a push rod (not shown), and the first sealing stopper 33 is moved to the distal end side by a dashed line in the drawing via distilled water. By moving to the position of 37, the distilled water in the second chamber 36 flows into the first chamber 35 and is mixed with the powdered medicine 30 in the first chamber, thereby dissolving the medicine to become a medicinal solution that can be administered. EE 'in the bypass section
As shown in FIG. 16, the outer periphery of the cylinder and the inner wall of the cylinder have the same thickness and are designed to protrude outward at the bypass portion 37.
【0005】[0005]
【発明が解決しようとする課題】上記した従来技術はい
ずれも注射器中の二種の薬の混合手段の改良を主として
目的としており、同一形状容器の薬の製剤上の問題に関
しては全く考慮していない。即ち、図15、図16のよ
うな形態の注射器兼容器では、製剤工程等で容器を保管
する空間として必要な体積が非常に大きくなること、ま
た粉末薬を充填した後の第1密封栓の嵌着や、第2室に
蒸留水等を充填した後の第2密封栓の嵌着の作業性が良
くなく特に衛生上も好ましくないことなどの問題があっ
た。そこで、本発明の解決しようとする基本的課題は、
薬の製剤、薬の保存、薬の混合、更には薬の投与という
各段階において一つの容器内に薬を保持して操作できる
と共に、製造上も保存時も薬投与時も衛生的且つ安定し
て用いることのできる注射器兼容器の構造の改良にあ
る。また、他の課題として特に抗生物質、酵素、ビタミ
ン、血清、ワクチンなどの不安定な薬品の製造、保存、
投与に適した注射器兼容器の構造の改良がある。All of the above-mentioned prior arts are mainly aimed at improving means for mixing two drugs in a syringe, and completely consider the problem of formulation of drugs in the same shape container. Absent. That is, in the case of the syringe / container in the form shown in FIGS. 15 and 16, the volume required as a space for storing the container in the preparation process or the like becomes very large, and the first sealing stopper after filling with the powdered drug is used. There was a problem that the workability of fitting and fitting of the second sealing plug after filling the second chamber with distilled water or the like was not good, and it was not particularly preferable in terms of hygiene. Therefore, the basic problem to be solved by the present invention is:
In each stage of drug formulation, drug preservation, drug mixing, and drug administration, the drug can be held and operated in a single container, and it is hygienic and stable in manufacturing, storage, and drug administration. Another object of the present invention is to improve the structure of a syringe / container that can be used. Other challenges include the production, storage, and storage of unstable drugs, especially antibiotics, enzymes, vitamins, serum, and vaccines.
There is an improvement in the structure of the syringe / container suitable for administration.
【0006】[0006]
【課題を解決するための手段】上記課題を解決するため
の手段として本発明は、一端に先端部を他端に開口部を
有する筒の略中央の位置の筒内壁面に筒長さ方向に走る
バイパスが設けられ、第1密封栓が該バイパスより筒開
口部寄りの位置において筒内面に嵌着されて筒先端部と
該第1密封栓との間に第1室を形成し、該第1密封栓よ
り筒開口部よりの位置において第2密封栓が筒内面に嵌
着されて該第1密封栓との間に第2室を形成した二室式
の注射器兼容器において、該バイパスは筒内壁面に凹形
溝状に1個又は複数個設けられ、筒外周は凹凸のない円
筒形状のものであり、且つ環状オレフィン系化合物又は
架橋多環式炭化水素系化合物を重合体成分とする樹脂を
含有する樹脂、又はオレフィン系化合物を重合体成分と
する樹脂、並びにこれらの樹脂とオレフィン系樹脂及び
/又は合成ゴムとの混合物からなることを特徴とする注
射器兼容器を提供する。本発明の注射器兼容器を、薬の
製造工程においては内部に重点した薬を乾燥または凍結
真空乾燥した後速やかにその室内にて密封するために、
また薬の保存、薬の混合、更には薬の投与に好適に用い
得るために、上記第1密封栓の筒軸方向の厚さが上記第
1バイパスの長さより短いものとすること、上記第1密
封栓及び/または第2密封栓表面が樹脂フィルムにて積
層されてなること、上記筒の先端内部を円形底部にし、
凹凸ができないようにゴム栓で密封し、該ゴム栓に両頭
針を装着し、固定できる形状にされてなることを本発明
の特に好ましい実施態様として挙げることができる。ま
た、該筒の開口部の筒入口部分の壁厚さが筒内部の壁厚
さより薄くなっているものは密封栓の押し込みが容易で
ある。As a means for solving the above-mentioned problems, the present invention is directed to a cylinder inner wall having a front end portion at one end and an opening portion at the other end, which is disposed substantially at the center of a cylinder inner wall surface. A running bypass is provided, and a first sealing plug is fitted to the inner surface of the cylinder at a position closer to the opening of the cylinder than the bypass to form a first chamber between the tip of the cylinder and the first sealing plug. In a two-chamber syringe / container in which a second sealing plug is fitted to the inner surface of the cylinder at a position closer to the cylinder opening than the first sealing plug to form a second chamber with the first sealing plug, the bypass is One or more concave grooves are provided on the inner wall surface of the cylinder, and the outer periphery of the cylinder is cylindrical without irregularities, and a cyclic olefin-based compound or a crosslinked polycyclic hydrocarbon-based compound is used as a polymer component. Resin containing resin, or resin containing olefinic compound as a polymer component, and Providing a syringe and container, characterized in that comprises a mixture of these resins and olefin resins and / or synthetic rubber. In order to seal the syringe / container of the present invention in the chamber immediately after drying or freeze-vacuum-drying the drug focused on the inside in the drug manufacturing process,
In addition, in order to be suitably used for preservation of medicine, mixing of medicine, and administration of medicine, the thickness of the first sealing stopper in the cylinder axis direction is shorter than the length of the first bypass. (1) that the surface of the sealing stopper and / or the second sealing stopper is laminated with a resin film, and that the inside of the tip of the cylinder has a circular bottom,
It is a particularly preferred embodiment of the present invention that the rubber stopper is sealed with a rubber stopper so as not to have irregularities, and the rubber stopper is formed in a shape that can be fixed by attaching a double-ended needle to the rubber stopper. If the wall thickness of the opening of the tube at the tube entrance is smaller than the wall thickness of the inside of the tube, it is easy to push the sealing plug.
【0007】[0007]
【作用及び実施例】本発明の注射器兼容器の構造、作用
機構及びその他の特徴を実施例を挙げて詳細に説明す
る。図1は本発明の一実施例の概略断面図であって、注
射器兼容器1の注射筒(以下、筒という)2の中央ほぼ
先端よりの筒内面に、筒長さ方向に走るバイパス溝(以
下、第1バイパスという)11を設け、該第1バイパス
11の長さより短い長さの第1密封栓8を、該第1バイ
パス11より筒2の筒開口部5寄りに位置させ、第1密
封栓8と筒先端部との間に第1室7を形成した。該第1
密封栓8より筒開口部5寄りの位置の筒内に第2密封栓
10を嵌着して前記第1密封栓8と第2密封栓10との
間に第2室9を形成して、二室からなる筒、容器とし
た。第1密封栓8と第2密封栓10とは外周に複数の環
状突起を有する弾性体からなり、図示の例では3個の環
状突起19,20,21を有していて、該突起の外径は
筒内径より若干大きく設計し、筒内に嵌着すると、筒内
面と密着して室内を密封でき、その上筒内面を移動でき
るようにしてある。このために、該第1密封栓8または
第2密封栓10の表面を樹脂フィルムで積層することも
できる。また、第2密封栓10には筒開口部方向に螺旋
形の窪12を設け、該窪12は図2に示す押し棒の先端
の螺旋形の突起13に嵌合するように設計する。筒2の
上部開口部5の末端15は円筒壁を筒内径が開口部に向
かい大きくなるようにテーパを形成し、前記第1密封栓
または第2密封栓の筒内への挿入を容易になるように設
計した。Operation and Embodiment The structure, operation mechanism and other features of the syringe / container of the present invention will be described in detail with reference to embodiments. FIG. 1 is a schematic cross-sectional view of an embodiment of the present invention, in which a bypass groove (running in the length direction of a cylinder) is formed in an inner surface of a syringe / container 1 at a position substantially at the center of a syringe tube (hereinafter, referred to as a tube) 2. A first sealing plug 8 having a length shorter than the length of the first bypass 11 is positioned closer to the cylinder opening 5 of the cylinder 2 than the first bypass 11, The first chamber 7 was formed between the sealing stopper 8 and the tip of the cylinder. The first
A second sealing plug 10 is fitted into the cylinder closer to the cylinder opening 5 than the sealing plug 8 to form a second chamber 9 between the first sealing plug 8 and the second sealing plug 10. A two-chamber tube and container were used. The first sealing plug 8 and the second sealing plug 10 are made of an elastic body having a plurality of annular projections on the outer periphery, and have three annular projections 19, 20, and 21 in the example shown in FIG. The diameter is designed to be slightly larger than the inner diameter of the cylinder, and when fitted in the cylinder, the interior is tightly contacted with the inner surface of the cylinder so that the interior of the room can be sealed and the inner surface of the upper cylinder can be moved. For this purpose, the surface of the first sealing plug 8 or the second sealing plug 10 can be laminated with a resin film. The second sealing plug 10 is provided with a spiral recess 12 in the direction of the opening of the cylinder, and the recess 12 is designed to fit into the spiral projection 13 at the tip of the push rod shown in FIG. The distal end 15 of the upper opening 5 of the cylinder 2 is tapered so that the inside diameter of the cylinder increases toward the opening to facilitate insertion of the first or second sealing plug into the cylinder. Designed to be.
【0008】図3、図6、図12はそれぞれ本発明の参
考例の概略説明図であって、これらの例では該筒2の第
2バイパス14のB−B′断面図を図5又は図13に示
すように設けてある。該第2バイパス溝の数は2〜8個
が好ましく、第1バイパス11は図4のA−A′断面図
に示すように、バイパス溝数1〜4個が好ましい。以上
の図に示した如く、本発明は注射筒の外表面に凸形を設
けることなく、筒内の内壁面に凹形の溝を設けた点、及
び特定の樹脂又は樹脂混合物で形成された点に特徴を有
する。FIGS. 3, 6, and 12 are schematic explanatory views of a reference example of the present invention. In these examples, a sectional view taken along the line BB 'of the second bypass 14 of the cylinder 2 is shown in FIGS. It is provided as shown in FIG. The number of the second bypass grooves is preferably 2 to 8, and the number of the first bypass 11 is preferably 1 to 4 as shown in the AA 'sectional view of FIG. As shown in the above figures, the present invention does not provide a convex shape on the outer surface of the injection cylinder, but forms a concave groove on the inner wall surface in the cylinder, and is formed of a specific resin or a resin mixture. It is characterized by points.
【0009】本発明において、図3に示すように筒2の
先端部3の内部に逆U字形ゴム栓4を装着してにて密封
し、かつ該ゴム栓4は筒2先端部3の内底に凹凸を設け
ないような形状にしてあり、針装着管6と共に両頭針1
6を先端に取り付け、固定できるようにすると共に、両
頭針16の内針先にて逆U字形ゴム栓4の中央を貫通し
得るような形状に設計したものも、特に好ましい実施態
様である。また、図6、図7も先端に両頭針16と逆U
字形ゴム栓を取り付けた本発明の参考例を示す。In the present invention, as shown in FIG. 3, an inverted U-shaped rubber plug 4 is mounted inside the distal end portion 3 of the cylinder 2 to seal it. The shape is such that there is no unevenness on the bottom.
A particularly preferable embodiment is designed so that the inner end of the double-ended needle 16 can penetrate the center of the inverted U-shaped rubber stopper 4 while the inner end of the double-ended needle 16 can be fixed. 6 and 7 also show a double-ended needle 16 and an inverted U
7 shows a reference example of the present invention in which a letter-shaped rubber stopper is attached.
【0010】本発明の注射器兼容器は図1に示す如く、
筒2の第1室7は濃縮薬または乾燥粉末薬の室とし、第
2室9には注射用蒸留水または希い薬液を充填し、第1
密封栓8にて分離し、第2密封栓10、ゴム栓4にて筒
2を密封し、2種類の薬を保存している。開口部または
両頭針をキャップ17にて包んで、エチレンオキサイド
ガス、γ線などにて殺菌し得るので、本発明は非常に衛
生的な注射器兼容器である。The syringe / container of the present invention, as shown in FIG.
The first chamber 7 of the cylinder 2 is a chamber for a concentrated drug or a dry powder drug, and the second chamber 9 is filled with distilled water for injection or a rare drug solution.
The tube 2 is separated by the sealing stopper 8 and the cylinder 2 is sealed by the second sealing stopper 10 and the rubber stopper 4, and two kinds of medicines are stored. Since the opening or the double-ended needle can be wrapped in the cap 17 and sterilized with ethylene oxide gas, γ-ray, or the like, the present invention is a very sanitary syringe and container.
【0011】図3に筒開口部に付属する指かけフランジ
23を示す。即ち、開口部、外周凹部22に指かけ凹部
を嵌合して固定する。該器具は注射薬の投与の際や押し
棒を移動する際に指をかける器具である。筒とは別に構
成されていて製剤工程(充填、凍結乾燥)では用いない
ので、これらの工程において筒の外形はシンプルな円筒
形状を保てる。FIG. 3 shows a finger hanging flange 23 attached to the cylindrical opening. That is, the finger hooking recess is fitted into the opening and the outer circumferential recess 22 and fixed. The device is a device for placing a finger when administering an injection or moving a push rod. Since it is constituted separately from the cylinder and is not used in the preparation process (filling, freeze-drying), the outer shape of the cylinder can be kept in a simple cylindrical shape in these steps.
【0012】図8,9は本発明の参考例であるが、薬の
製剤、即ち希い薬液を濃縮する、特に凍結真空乾燥製剤
に、本発明の注射器兼容器の使用が適した構造体である
ことを説明している。筒2の先端3をゴム栓4で密封
し、筒内に薬の原料である薄い薬液25の適当量を仕込
み、殺菌した乾燥室(真空にでき、入れ込む空気は殺菌
できる)において、不安定なる薬例えば抗生物質、酵
素、ビタミン類のような熱、酸素の影響をうけやすい薬
の製剤には原液を凍結して真空乾燥が行われ、その条件
は例えば室温度は−10〜−60℃、即ち液体窒素ガス
を使用しての冷却、真空度10-3〜10Torrと極め
て厳しい条件下での薬の濃縮、乾燥を行うのに好ましい
形状をしている。図8に示すように第2バイパスと筒2
開口部を接近させ、溝を2〜8本と多量に、またその面
積を広く設けてあり、そのバイパス中には多環状の厚い
第1密封栓が装入されているので、該第2バイパス14
を乾燥中に濃縮薬25の蒸気26が通過することは、蒸
留塔の効果を示すことになる。また第1密封栓より短い
第2バイパスにすると装置コストを低下できまた蒸気通
路を短くするので再析出等を防ぐことができる。FIGS. 8 and 9 show a reference example of the present invention, which is a structure suitable for use in a drug formulation, that is, for concentrating a dilute drug solution, especially for a freeze-vacuum-dried formulation. Explain that there is. The distal end 3 of the cylinder 2 is sealed with a rubber stopper 4, and an appropriate amount of a thin chemical solution 25, which is a raw material of a medicine, is charged into the cylinder, and is unstable in a sterilized drying chamber (a vacuum can be created, and the air to be introduced can be sterilized). For the preparation of drugs that are easily affected by heat or oxygen, such as antibiotics, enzymes, and vitamins, the stock solution is frozen and vacuum-dried. The conditions are, for example, a room temperature of -10 to -60C. That is, it has a preferable shape for cooling using liquid nitrogen gas and concentrating and drying the drug under extremely severe conditions of a vacuum degree of 10 -3 to 10 Torr. As shown in FIG.
The opening is made closer, a large number of grooves such as 2 to 8 grooves are provided, and the area thereof is widened. In the bypass, a thick multi-annular first sealing plug is inserted. 14
The passage of the vapor 26 of the concentrate 25 during the drying of the liquor indicates the effect of the distillation column. If the second bypass is shorter than the first sealing plug, the cost of the apparatus can be reduced, and the vapor passage can be shortened, so that re-deposition can be prevented.
【0013】また本発明の参考例においては第2バイパ
スの長さを第1密封栓の厚さより短く、かつ第1密封栓
の厚さの1/3〜等倍好ましくは1/2〜等倍とするこ
ともできる。図12の筒2は図8の第2バイパスの場合
の約1/2の長さの第2バイパスを有するが、図12の
例では第1密封栓は筒内壁に固定され、乾燥する蒸気2
6は図8の場合と同様にバイパス14を通り蒸発するこ
とができる。図13に図12のB−B′断面図を示す。
さらに図14に、第2バイパスの長さを第1密封栓の厚
さの約1/3より若干長い程度にした例を筒の中心軸に
垂直な面での断面と該断面のC−C′方向、D−D′方
向の筒軸方向部分断面図を示した。第2バイパスは短い
が図示のように筒内壁に十分固定され、薬の濃縮乾燥時
の蒸気は第2バイパス溝から排気できる。この例では排
気通路が短いので製造装置を小さくできるに加え、排気
等が再析出することがない。ただし第1密封栓の1/3
より短いバイパスにすると、乾燥室内で第1密封栓を第
2バイパスに押入れる作業や、乾燥時に筒内壁に該密封
栓を安定に保持することが困難になる。In the embodiment of the present invention, the length of the second bypass is shorter than the thickness of the first sealing plug, and is 1/3 to 1 times, preferably 1/2 to 1 times the thickness of the first sealing plug. It can also be. The cylinder 2 in FIG. 12 has a second bypass having a length of about の that of the second bypass in FIG. 8, but in the example of FIG.
6 can be evaporated through the bypass 14 as in the case of FIG. FIG. 13 is a sectional view taken along the line BB 'of FIG.
FIG. 14 shows an example in which the length of the second bypass is set to be slightly longer than about 1/3 of the thickness of the first sealing plug. ′ Direction and DD ′ direction in the axial direction of the cylinder. Although the second bypass is short, it is sufficiently fixed to the inner wall of the cylinder as shown in the figure, and the vapor during the concentration and drying of the medicine can be exhausted from the second bypass groove. In this example, since the exhaust passage is short, the manufacturing apparatus can be reduced in size, and exhaust and the like do not reprecipitate. However, 1/3 of the first sealing stopper
If the bypass is shorter, it is difficult to push the first sealing plug into the second bypass in the drying chamber or to stably hold the sealing plug on the inner wall of the cylinder during drying.
【0014】本発明の注射器兼容器が上記条件に適して
いる理由は以下のとおりである。 (1)筒2の外形は円形であって、第1バイパス、第2
バイパスを内壁に凹形窪みとして設けてあるため、例え
ば凍結乾燥室での処理の際、冷媒すなわち液体窒素の流
れが良好となり、また外形が円形である筒は網形固定具
で、相互に接触するように接近して配置することができ
るため、単位面積当たりの処理容器本数が最大になり、
従来のバイパス部が筒の外側に突き出したものと比べ多
量に乾燥室内に入れることができる。また装置建設経
費、製造単位コストなどの経済性が有利になる。 (2)筒2の先端3を丸底にし、注射針の窪を逆U字型
ゴム栓で密封し、できるだけ凹凸をなくした設計にし
た。即ち筒先端底に存在している薬液も、凍結しても速
やかに乾燥できる。 (3)筒2内の濃縮薬が十分濃縮乾燥されて粉薬になっ
た時に、当該乾燥室内で、図9に示すように第1密封栓
8を押入具28にて作動させ、筒2内の中央部、第1バ
イパス11の上部まで挿入することにより、乾燥粉末を
密封することができる。以上の構成により、乾燥室内、
特に凍結真空乾燥・殺菌室内にて、筒2内に第1密封栓
で注射薬を密封することができる。このような製剤工程
に必要なる条件を十分に満足できる。The reason why the syringe / container of the present invention is suitable for the above conditions is as follows. (1) The outer shape of the cylinder 2 is circular, and the first bypass and the second
Since the bypass is provided as a concave depression on the inner wall, the flow of the refrigerant, that is, liquid nitrogen, is good during processing in, for example, a freeze-drying chamber. The number of processing vessels per unit area is maximized,
A larger amount can be put into the drying chamber than a conventional bypass portion protruding outside the cylinder. In addition, economy such as equipment construction cost and manufacturing unit cost becomes advantageous. (2) The tip 3 of the cylinder 2 was made round bottom, and the recess of the injection needle was sealed with an inverted U-shaped rubber stopper, and the design was made as uneven as possible. In other words, the chemical solution present at the bottom of the tube tip can be dried quickly even if frozen. (3) When the concentrated medicine in the cylinder 2 is sufficiently concentrated and dried to be powdered, the first sealing plug 8 is operated by the push-in tool 28 in the drying chamber as shown in FIG. The dry powder can be hermetically sealed by inserting it into the central part and the upper part of the first bypass 11. With the above configuration, the drying room,
In particular, the injection can be sealed in the cylinder 2 with the first sealing stopper in the freeze vacuum drying / sterilization chamber. The conditions required for such a formulation process can be sufficiently satisfied.
【0015】多くの薬のうち、空気中でも安定で、加熱
殺菌できる薬粉末については、単なる殺菌室内におい
て、本発明の筒2に第1バイパスのみを有する注射器に
おいては、濃縮粉末薬を第1室に、第2室には希釈薬又
は蒸留水の二薬を充填することができる容器になる。図
9の操作の工程で、第1密封栓8にて第1室を密封した
筒2を、該乾燥室外に出し、殺菌室にて筒2の第2室9
に希釈薬又は注射用蒸留水(以下、蒸留水と略す)を充
填し、速やかに、第2密封栓10を打栓し、さらにキャ
ップ17をつけて完成した製品になる。Among many drugs, drug powders that are stable even in the air and can be sterilized by heat are stored in a mere sterilization chamber in a syringe having only the first bypass in the cylinder 2 of the present invention. In addition, the second chamber is a container that can be filled with a diluent or two drugs of distilled water. In the operation step shown in FIG. 9, the cylinder 2 in which the first chamber is sealed with the first sealing stopper 8 is taken out of the drying chamber, and the second chamber 9 of the cylinder 2 is placed in the sterilization chamber.
Is filled with a diluent or distilled water for injection (hereinafter abbreviated as distilled water), the second sealing stopper 10 is quickly stoppered, and the cap 17 is further attached to obtain a completed product.
【0016】本発明では、第1密封栓および第2密封栓
で筒内の二室に薬、蒸留水を完全に密封するために、該
栓の直径を筒内径より3〜14%太く設計することが好
ましい。また筒2の開口末端15は開口部に向かいテー
パ状に肉薄に、即ち内径を太くすることにより、第1密
封栓及び第2密封栓の該筒2内への挿入を容易にした。In the present invention, the diameter of the stopper is designed to be 3 to 14% larger than the inner diameter of the cylinder in order to completely seal the medicine and distilled water in the two chambers in the cylinder with the first sealing stopper and the second sealing stopper. Is preferred. In addition, the opening end 15 of the cylinder 2 is tapered toward the opening and is made thinner, that is, the inner diameter is increased, so that the first sealing plug and the second sealing plug can be easily inserted into the cylinder 2.
【0017】次に本発明の注射器兼容器内に保存した薬
品を投与する方法を具体的に説明する。図10に示すよ
うに本発明の注射器兼容器の参考例に充填された薬を使
用に際して、筒2の開口部5のキャップ17をはずし、
図3に示した指かけフランジ23を挿入する。次に図2
の押し棒先端螺旋部13を、筒2の第2密封栓10の凹
形螺旋12内に挿入し、押し棒を筒2の先端部3方向に
圧入すると第1密封栓8が第1バイパス11の位置に近
づき、蒸留水は第1バイパスを流れて、第1室7に入
り、濃縮薬又は粉末薬と蒸留水を混合して、希釈した投
与できる薬液になる。この時点で図11に示すように筒
先部3に位置するゴム栓4に両頭針16を挿入し、両頭
針16中の空気を除き、押し棒を筒先部に押し入れるこ
とにより希釈薬液を投与することができる。以上のよう
に、本発明の注射器兼容器は、簡単なる操作で、速やか
に且つ衛生的に薬液を調製し、直ちに投与できる注射器
兼容器である。Next, the method of administering the medicine stored in the syringe / container of the present invention will be specifically described. As shown in FIG. 10, when using the medicine filled in the syringe / container reference example of the present invention, the cap 17 of the opening 5 of the cylinder 2 is removed,
The finger hook 23 shown in FIG. 3 is inserted. Next, FIG.
When the push rod tip spiral portion 13 is inserted into the concave spiral 12 of the second sealing plug 10 of the cylinder 2 and the push rod is pressed into the distal end portion 3 of the cylinder 2, the first sealing plug 8 is turned into the first bypass 11. , The distilled water flows through the first bypass and enters the first chamber 7, where the concentrated or powdered drug and the distilled water are mixed to obtain a diluted and administrable liquid medicine. At this time, as shown in FIG. 11, the double-ended needle 16 is inserted into the rubber stopper 4 located at the cylinder tip portion 3, the air in the double-ended needle 16 is removed, and the push rod is pushed into the cylinder tip portion to administer the diluent drug solution. be able to. As described above, the syringe / container of the present invention is a syringe / container that can quickly and hygienically prepare a drug solution with a simple operation and immediately administer it.
【0018】本発明の注射器兼容器に使用する注射筒の
素材としては、環状オレフィン系化合物又は架橋多環式
炭化水素系化合物を重合体成分とする樹脂を含有する樹
脂、又はオレフィン系化合物を重合体成分とする樹脂、
並びにこのような樹脂に更にオレフィン系樹脂及び/又
は合成ゴム類を混合してなる混合物を用いる。上記素材
に更に他の樹脂、例えばポリエチレン、ポリプロピレ
ン、ポリエチレンテレフタレート、エチレン−ビニルア
ルコール、エチレン−ビニル共重合体、エチレン−酢酸
ビニル共重合体、ナイロン及びアモルファスナイロン、
エチレンプロピレン共重合樹脂、ポリメチルペンテン、
エチレン−ブチル共重合体等を1層以上積層することも
できる。As the material of the syringe used in the syringe and container of the present invention, a resin containing a resin containing a cyclic olefin compound or a crosslinked polycyclic hydrocarbon compound as a polymer component, or an olefin compound is used. Resin as a coalescing component,
A mixture obtained by further mixing an olefin resin and / or a synthetic rubber with such a resin is used. Further resins in the above materials, for example, polyethylene, polypropylene, polyethylene terephthalate, ethylene-vinyl alcohol, ethylene-vinyl copolymer, ethylene-vinyl acetate copolymer, nylon and amorphous nylon,
Ethylene propylene copolymer resin, polymethylpentene,
One or more layers of an ethylene-butyl copolymer or the like can be laminated.
【0019】第1密封栓又は第2密封栓の部分はゴム弾
性を必要とするのでその素材としては、合成ゴム即ちイ
ソプレン、ポリブタジエン、エチレンプロピレンターポ
リマー、イソプレン−イソブチレン共重合体、熱可塑性
エラストマーなどの架橋体が耐熱性を有する点でも好ま
しい。更に、該密封栓の一部を積層する樹脂フィルムと
しては、フッ素系樹脂、環状オレフィン系化合物又は架
橋多環式炭化水素系化合物を重合体成分とする樹脂、汎
用オレフィン系化合物を重合体成分とする樹脂からなる
ものが好ましい。Since the first sealing plug or the second sealing plug needs rubber elasticity, its material may be synthetic rubber, ie, isoprene, polybutadiene, ethylene propylene terpolymer, isoprene-isobutylene copolymer, thermoplastic elastomer, etc. The crosslinked product is also preferable in that it has heat resistance. Further, as the resin film for laminating a part of the sealing plug, a resin containing a fluorine-based resin, a cyclic olefin-based compound or a crosslinked polycyclic hydrocarbon-based compound as a polymer component, and a general-purpose olefin-based compound as a polymer component It is preferable that the resin is made of a resin.
【0020】[0020]
【発明の効果】本発明の二室式注射器兼容器は、(1)
注射筒のバイパス溝が筒外周に突起を形成することな
く、筒内に二段階に設けたことにより、薬の製剤室内に
おいて原薬液を濃縮、乾燥、粉末化し、速やかに該注射
器兼容器の室内に密封することができるので、衛生的で
経済的なる容器である。(2)第1バイパス、第1密封
栓、筒先端の形状が目的に合致するよう最適な形態に設
計して組み合わせてあるので、薄く、熱、空気で分解し
易い原薬も速やかに濃縮し、安定な高品位な薬に製剤す
ることができる効果を奏する。(3)本発明の注射器兼
容器は保持した薬物を高品位に長期に保存できる。According to the present invention, the two-chamber syringe / container is (1)
By providing the bypass groove of the injection cylinder in the cylinder in two stages without forming a protrusion on the outer periphery of the cylinder, the drug substance solution is concentrated, dried, and powdered in the drug formulation chamber, and the chamber of the syringe / container is quickly opened. The container is hygienic and economical because it can be sealed. (2) The first bypass, the first sealing plug, and the tip of the cylinder are designed and combined in an optimal form so as to meet the purpose, so that the drug substance that is thin and easily decomposed by heat and air is also concentrated quickly. It is effective in being able to be formulated into a stable, high-quality drug. (3) The syringe / container of the present invention can store the held drug in high quality for a long time.
【図1】は本発明の注射器兼容器の一実施例を説明する
概略断面図である。FIG. 1 is a schematic sectional view illustrating an embodiment of a syringe and a container according to the present invention.
【図2】は押し棒の説明図である。FIG. 2 is an explanatory diagram of a push rod.
【図3】は本発明の注射器兼容器の参考例を説明する概
略断面図である。FIG. 3 is a schematic sectional view illustrating a reference example of a syringe and container according to the present invention.
【図4】は図1、図6の第1バイパス部分のA−A′断
面図である。FIG. 4 is a sectional view taken along line AA ′ of a first bypass portion in FIGS. 1 and 6;
【図5】は図1、図6の第2バイパス部分のB−B′断
面図である。FIG. 5 is a sectional view taken along line BB ′ of the second bypass portion in FIGS. 1 and 6;
【図6】は本発明の注射器兼容器の他の参考例を説明す
る概略断面図である。FIG. 6 is a schematic cross-sectional view illustrating another reference example of a syringe and a container of the present invention.
【図7】は図6に示した本発明の注射器兼容器に取り付
ける両頭針の断面図である。FIG. 7 is a cross-sectional view of a double-ended needle attached to the syringe / container of the present invention shown in FIG.
【図8】は本発明の注射器兼容器を用いて薄い濃度の薬
液を濃縮する製剤状況を示す概略説明図である。FIG. 8 is a schematic explanatory view showing the condition of a preparation for concentrating a drug solution having a low concentration using a syringe and a container of the present invention.
【図9】は図8の工程に続き筒の中に第1密封栓を押入
れた状態を示す概略説明図である。FIG. 9 is a schematic explanatory view showing a state in which the first sealing plug is pushed into the cylinder following the step of FIG. 8;
【図10】は本発明の注射器兼容器の使用に際して、押
し棒を押し込み、薬液、第1密封栓を圧入して薬液がバ
イパスを通り第1室に流入する状態を示す概略説明図で
ある。FIG. 10 is a schematic explanatory view showing a state in which a push rod is pushed in to use a syringe and a container of the present invention, and a drug solution and a first sealing stopper are press-fitted and a drug solution flows into a first chamber through a bypass.
【図11】は本発明の注射器兼容器に両頭針を挿入して
薬液を投与する状態を示す概略説明図である。FIG. 11 is a schematic explanatory view showing a state in which a double-ended needle is inserted into the syringe / container of the present invention to administer a drug solution.
【図12】は本発明の注射器兼容器の他の実施例であっ
て、図8の場合の約1/2長さの第2バイパスを設けた
例を説明する概略断面図である。FIG. 12 is a schematic cross-sectional view illustrating another embodiment of the syringe / container according to the present invention, in which a second bypass having a length of about 1/2 of that in FIG. 8 is provided.
【図13】は図12の第2バイパス部分のB−B′断面
図である。FIG. 13 is a sectional view taken along line BB 'of the second bypass portion in FIG.
【図14】は本発明の注射器兼容器の他の参考例であっ
て、短い第2バイパスを設けた例を断面及び部分断面で
示す説明図である。FIG. 14 is an explanatory view showing a cross section and a partial cross section of another reference example of the syringe and container of the present invention, in which a short second bypass is provided.
【図15】は従来の二室式注射器兼容器において、注射
筒外周に突出したバイパスを示す概略説明図である。FIG. 15 is a schematic explanatory view showing a bypass projecting to the outer periphery of an injection cylinder in a conventional dual-chamber syringe / container.
【図16】は図14の従来の二室式注射器兼容器のE−
E′断面図である。FIG. 16 shows E- of the conventional dual-chamber syringe / container of FIG.
It is E 'sectional drawing.
1 注射器兼容器、 2 筒、 3 先端部、 4 ゴ
ム栓、 5 筒開口部、 6 針装着管、 7 第1
室、 8 第1密封栓、 9 第2室、 10第2密封
栓、 11 第1バイパス、 12 凹形螺旋、 13
凸形螺旋、14 第2バイパス、 15 開口部の末
端、 16 両頭針、 17 開口部又は先端キャッ
プ、 18 ゴムパッキン、 19 環状突起、 20
環状突起、 21 環状突起、 22 開口部外周の
窪み、 23 指かけフランジ、24 枠型固定具、
25 源の薄い薬液、 26 蒸気、 27 濃縮薬
(粉末薬)、 28 押し棒(乾燥室での第1密封栓の
筒内押入具)、 29 注射筒、 30 筒先端、 3
1 筒開口部、32 フランジ、 33 第1密封栓、
34 第2密封栓、 35 第一室、 36 第二
室、 37 バイパス。1 syringe and container, 2 cylinders, 3 tip, 4 rubber stopper, 5 cylinder opening, 6 needle mounting tube, 7 first
Chamber, 8 first sealing stopper, 9 second chamber, 10 second sealing stopper, 11 first bypass, 12 concave spiral, 13
Convex spiral, 14 second bypass, 15 end of opening, 16 double-ended needle, 17 opening or tip cap, 18 rubber packing, 19 annular projection, 20
Annular projections, 21 annular projections, 22 depressions around the opening, 23 finger flanges, 24 frame-type fixtures,
25 thin liquid medicine of source, 26 vapor, 27 concentrated medicine (powder medicine), 28 push rod (in-cylinder insertion tool of the first sealing stopper in the drying chamber), 29 syringe barrel, 30 tip of cylinder, 3
1 cylinder opening, 32 flange, 33 first sealing plug,
34 second sealing stopper, 35 first chamber, 36 second chamber, 37 bypass.
Claims (4)
の略中央の位置の筒内壁面に筒長さ方向に走るバイパス
が設けられ、第1密封栓が該バイパスより筒開口部寄り
の位置において筒内面に嵌着されて筒先端部と該第1密
封栓との間に第1室を形成し、該第1密封栓より筒開口
部よりの位置において第2密封栓が筒内面に嵌着されて
該第1密封栓との間に第2室を形成した二室式の注射器
兼容器において、該バイパスは筒内壁面に凹形溝状に1
個又は複数個設けられ、筒外周は凹凸のない円筒形状の
ものであり、且つ環状オレフィン系化合物又は架橋多環
式炭化水素系化合物を重合体成分とする樹脂を含有する
樹脂、又はオレフィン系化合物を重合体成分とする樹
脂、並びにこれらの樹脂とオレフィン系樹脂及び/又は
合成ゴムとの混合物からなることを特徴とする注射器兼
容器。1. A bypass running in the length direction of a cylinder is provided on an inner wall surface of the cylinder at a position substantially at the center of the cylinder having an end at one end and an opening at the other end. At a position closer to the inner surface of the cylinder, a first chamber is formed between the distal end of the cylinder and the first sealing plug, and the second sealing plug is located at a position closer to the cylinder opening than the first sealing plug. In a two-chamber syringe / container fitted to the inner surface to form a second chamber between the first sealing stopper and the first sealing stopper, the bypass has a concave groove shape on the inner wall surface of the cylinder.
A resin or a resin containing a resin having a polymer component of a cyclic olefin-based compound or a crosslinked polycyclic hydrocarbon-based compound, or a olefin-based compound. And a mixture of these resins with an olefin resin and / or a synthetic rubber.
第1バイパスの長さより短いものである請求項1記載の
注射器兼容器。2. The syringe and container according to claim 1, wherein the thickness of the first sealing plug in the cylinder axis direction is shorter than the length of the first bypass.
表面が樹脂フィルムにて積層されてなることを特徴とす
る請求項1又は2に記載の注射器兼容器。3. The syringe and container according to claim 1, wherein the surface of the first sealing stopper and / or the second sealing stopper is laminated with a resin film.
ができないようにゴム栓で密封し、該ゴム栓に両頭針を
装着し、固定できる形状にされてなることを特徴とする
請求項1ないし3のいずれかに記載の注射器兼容器。4. The cylinder according to claim 1, wherein the inside of the tip of the cylinder has a circular bottom and is sealed with a rubber stopper so as not to have irregularities, and a double-ended needle is attached to the rubber stopper and fixed. 4. The syringe and container according to any one of 1 to 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000400690A JP3471318B2 (en) | 1992-11-27 | 2000-12-28 | Syringe and container |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4-318583 | 1992-11-27 | ||
JP31858392 | 1992-11-27 | ||
JP2000400690A JP3471318B2 (en) | 1992-11-27 | 2000-12-28 | Syringe and container |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21294993A Division JP3172005B2 (en) | 1992-11-27 | 1993-08-27 | Syringe and container |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001212236A true JP2001212236A (en) | 2001-08-07 |
JP3471318B2 JP3471318B2 (en) | 2003-12-02 |
Family
ID=26569414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000400690A Expired - Lifetime JP3471318B2 (en) | 1992-11-27 | 2000-12-28 | Syringe and container |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3471318B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003052823A (en) * | 2001-08-21 | 2003-02-25 | Takeda Chem Ind Ltd | Two-chamber type pre-filled syringe |
JP2009506814A (en) * | 2005-09-02 | 2009-02-19 | ラボラトアール アゲータン | Syringe pre-filled and then configured to be sterilized with autoclave |
JP2019504736A (en) * | 2016-02-09 | 2019-02-21 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 2-chamber carpule |
WO2022190982A1 (en) * | 2021-03-08 | 2022-09-15 | テルモ株式会社 | Pre-filled syringe |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2549417A (en) * | 1949-08-10 | 1951-04-17 | Frederick M Turnbull | Syringe ampoule |
JPS5722766A (en) * | 1979-10-09 | 1982-02-05 | Terumo Corp | Syringe |
JPS595046A (en) * | 1982-06-30 | 1984-01-11 | Touritsu Kogyo:Kk | Production of medical rubber article |
JPS62139668A (en) * | 1985-12-16 | 1987-06-23 | 株式会社大協精工 | Laminated plug for syringe |
JPS62252407A (en) * | 1986-04-26 | 1987-11-04 | Mitsui Petrochem Ind Ltd | Cycloolefin random copolymer |
JPS6377456A (en) * | 1986-09-19 | 1988-04-07 | 株式会社大協精工 | Medical and medicinal rubber product |
JPH01197511A (en) * | 1988-02-01 | 1989-08-09 | Mitsui Petrochem Ind Ltd | New random olefin copolymer |
JPH0258446U (en) * | 1988-10-21 | 1990-04-26 | ||
JPH043574Y2 (en) * | 1985-03-05 | 1992-02-04 | ||
JPH0477948U (en) * | 1990-11-19 | 1992-07-07 | ||
JPH04322662A (en) * | 1990-02-07 | 1992-11-12 | Arzneimittel Gmbh Apotheker Vetter & Co Ravensburg | Mixing method for medical substance which is filled in duel chamber syringe, and syringe to perform this method |
-
2000
- 2000-12-28 JP JP2000400690A patent/JP3471318B2/en not_active Expired - Lifetime
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2549417A (en) * | 1949-08-10 | 1951-04-17 | Frederick M Turnbull | Syringe ampoule |
JPS5722766A (en) * | 1979-10-09 | 1982-02-05 | Terumo Corp | Syringe |
JPS595046A (en) * | 1982-06-30 | 1984-01-11 | Touritsu Kogyo:Kk | Production of medical rubber article |
JPH043574Y2 (en) * | 1985-03-05 | 1992-02-04 | ||
JPS62139668A (en) * | 1985-12-16 | 1987-06-23 | 株式会社大協精工 | Laminated plug for syringe |
JPS62252407A (en) * | 1986-04-26 | 1987-11-04 | Mitsui Petrochem Ind Ltd | Cycloolefin random copolymer |
JPS6377456A (en) * | 1986-09-19 | 1988-04-07 | 株式会社大協精工 | Medical and medicinal rubber product |
JPH01197511A (en) * | 1988-02-01 | 1989-08-09 | Mitsui Petrochem Ind Ltd | New random olefin copolymer |
JPH0258446U (en) * | 1988-10-21 | 1990-04-26 | ||
JPH04322662A (en) * | 1990-02-07 | 1992-11-12 | Arzneimittel Gmbh Apotheker Vetter & Co Ravensburg | Mixing method for medical substance which is filled in duel chamber syringe, and syringe to perform this method |
JPH0477948U (en) * | 1990-11-19 | 1992-07-07 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003052823A (en) * | 2001-08-21 | 2003-02-25 | Takeda Chem Ind Ltd | Two-chamber type pre-filled syringe |
JP2009506814A (en) * | 2005-09-02 | 2009-02-19 | ラボラトアール アゲータン | Syringe pre-filled and then configured to be sterilized with autoclave |
JP2019504736A (en) * | 2016-02-09 | 2019-02-21 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 2-chamber carpule |
US11077021B2 (en) | 2016-02-09 | 2021-08-03 | Sanofi-Aventis Deutschland Gmbh | Two-chamber carpule |
WO2022190982A1 (en) * | 2021-03-08 | 2022-09-15 | テルモ株式会社 | Pre-filled syringe |
Also Published As
Publication number | Publication date |
---|---|
JP3471318B2 (en) | 2003-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3172005B2 (en) | Syringe and container | |
JPH0412990Y2 (en) | ||
CA1269579A (en) | Syringe barrel assembly | |
US10456526B2 (en) | Multi-compartment pre-filled mixing syringes with bypass | |
US4657534A (en) | Dual compartment, disposable, mixing and dispensing container | |
JPH0340297Y2 (en) | ||
US3946732A (en) | Two-chamber mixing syringe | |
EP0664137B1 (en) | Syringe and method for lyophilizing and reconstituting injectable medication | |
US4639250A (en) | Syringe barrel and hypodermic needle assembly | |
HU215631B (en) | Method and cartridge assembly for lyophilizing and closing of a compound in a cartridge | |
US4581015A (en) | Multimedication syringe | |
JP2001112867A (en) | Syringe containing drug | |
JPH06500939A (en) | injection unit | |
JP2001212236A (en) | Syringe/container | |
JP3982855B2 (en) | Syringe combining two chambers | |
JP3117900B2 (en) | Syringe and container | |
JP3015220B2 (en) | Syringe and container | |
JP2001017546A (en) | Drug solution dispensing device and method for manufacturing the same | |
JPH07246238A (en) | Injector assembly | |
JP3607464B2 (en) | Chemical injection device | |
JP3015285B2 (en) | Syringe and container | |
JP4004106B2 (en) | Chemical injection device | |
JPH11332984A (en) | Medicinal liquid-containing syringe | |
JP4026871B2 (en) | Syringe combining two chambers | |
EP0728492A2 (en) | Dual chamber internal by-pass syringe assembly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20030902 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080912 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080912 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090912 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090912 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090912 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100912 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100912 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110912 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110912 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120912 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120912 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120912 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130912 Year of fee payment: 10 |
|
EXPY | Cancellation because of completion of term |